Inflammation and Diabetes: Evaluating Antioxidant Levels

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorIstanbul Bilgi University

About this trial

The goal of this observational, cross-sectional study is to evaluate the relationships between dietary total antioxidant capacity, systemic inflammatory response markers, and nutritional parameters in adult patients with Type 2 Diabetes (T2DM). Participants will be classified into controlled (HbA1c \< %7) and uncontrolled (HbA1c ≥ %7) diabetes groups based on their glycemic control. The main questions it aims to answer are: Does dietary antioxidant capacity affect systemic inflammation levels and metabolic parameters? Is there a relationship between nutritional risk status and inflammatory response in T2DM patients?

Eligibility criteria

Qualifiers

Adults aged 18 and older diagnosed with Type 2 Diabetes.

Individuals whose biochemical analyses have been performed by a physician within the last 1 month.

Individuals willing to participate voluntarily.

Disqualifiers

Missing required laboratory data in the last 1 month.

Presence of acute infection or inflammatory disease.

Advanced kidney or liver failure.

Active malignancy or receiving chemotherapy/radiotherapy.

Trial design

Treatments tested in this trial

  • No Interventions

Treatment groups

180 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Istanbul Bilgi University

Lead sponsor

İstanbul Gaziosmanpaşa Training and Research Hospital

Collaborator